Dublin, April 17, 2023 (GLOBE NEWSWIRE) — The report “Global Digital Therapeutics for Behavioral Health Market – 2022 Report” has been added to ResearchAndMarkets.coms to offer.
In 2021, worldwide sales of digital therapies for behavioral disorders were estimated to be approximately $625.0 million.
The global prevalence of mental disorders has grown from an estimated 650 million in 1990 to 970 million in 2019. The COVID-19 pandemic exacerbated the problem, with anxiety and depression rates increasing by 25% in the first year of the pandemic.
Market drivers include the increasing prevalence of mental disorders worldwide, the rapid expansion of telemedicine during the COVID-19 pandemic, increasing internet access and smartphone penetration, positive regulatory changes for digital therapies, and the cost-effectiveness of digital therapy compared to traditional systems for mental healthcare.
Constraints in this market include lack of reimbursement for digital therapies in many regions of the world, difficulties in monitoring patient adherence, delayed progress of clinical trials during the COVID-19 pandemic, and the low priority of mental health worldwide .
This analysis includes a discussion of products, current/expected markets, competitors and opportunities in the global markets for digital behavioral health therapies; these include products intended for the treatment of major depressive disorder, stress/mild anxiety, anxiety disorder (including more serious conditions such as panic disorder and post-traumatic stress disorder), and substance use disorder (including alcohol and opioid dependence, among others).
Countries covered in this report include the US, five major European markets (France, Germany, Italy, Spain and the UK), Japan and the rest of the world. The forecast range for this report is 2021-26.
Main topics:
1. Overview of Digital Therapies for Behavioral Health
2. Digital therapy for behavioral health
2.1 Behavioral therapeutic treatment techniques
2.1.1 Digital Therapies and Pharmaceuticals
2.1.2 Artificial intelligence
2.2 Scheme and compensation
2.2.1 US
Regulation of mobile appsSoftwareDigital Health Initiative
2.2.2 Europe
2.2.3 Japan
2.2.4 Worldwide
2.3 Clinical Trials
2.4 Digital Therapies for Major Depressive Disorder
2.4.1 HelloBetter
2.4.2 Orexo
2.4.3 Limbix Health
2.4.4 Emerging Technologies
2.5 Digital therapies for stress/mild anxiety
2.5.1 BehaviorVR
2.5.2 Quiet health
2.5.3 Livongo Health/Teladoc Health
2.5.4 Emerging Technologies
2.6 Digital Therapies for Anxiety Disorder
2.6.1 Freespira
2.6.2 HelloBetter
2.6.3 Nightwear
2.7 Digital Therapies for Substance Use Disorders
2.7.1 HelloBetter
2.7.2 Orexo
2.7.3 Pear therapies
2.7.4 SilverCloud/Amwell
2.7.5 Emerging Technologies
2.8 Bibliography
3. Digital Therapy for Behavioral Health Market
3.1 Global Market Analysis
3.1.1 Market Drivers and Limiters
3.1.2 Market Leaders and Competitive Strategies
Headspace HealthWysaSilverCloudTwillPear Therapeutics
3.1.3 Emerging competition
3.2 Regional trends
3.2.1 US
3.2.2 Five major European markets
3.2.3 Japan
3.2.4 Rest of the world
3.3 Market Forecast
3.3.1 Digital Therapies for Major Depressive Disorder Market Forecast
3.3.2 Digital Therapies for Stress/Mild Anxiety Market Forecast
3.3.3 Digital Therapies for Anxiety Disorder Market Forecast
3.3.4 Digital Therapies for Addiction Problems, Market Forecast
3.4 Bibliography
For more information on this report, please visit https://www.researchandmarkets.com/r/uyvi5c
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
